215 related articles for article (PubMed ID: 17881495)
41. Interaction of PKCα with the armadillo repeats facilitates the N-terminal phosphorylation of β-catenin.
Gwak J; Yoo YS; Choi YJ; Oh S
Biochem Biophys Res Commun; 2014 Aug; 450(4):1673-8. PubMed ID: 25058461
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of protein-protein interactions: the discovery of druglike beta-catenin inhibitors by combining virtual and biophysical screening.
Trosset JY; Dalvit C; Knapp S; Fasolini M; Veronesi M; Mantegani S; Gianellini LM; Catana C; Sundström M; Stouten PF; Moll JK
Proteins; 2006 Jul; 64(1):60-7. PubMed ID: 16568448
[TBL] [Abstract][Full Text] [Related]
43. Migfilin and its binding partners: from cell biology to human diseases.
Wu C
J Cell Sci; 2005 Feb; 118(Pt 4):659-64. PubMed ID: 15701922
[TBL] [Abstract][Full Text] [Related]
44. Self-regulation of functional pathways by motifs inside the disordered tails of beta-catenin.
Zhao B; Xue B
BMC Genomics; 2016 Aug; 17 Suppl 5(Suppl 5):484. PubMed ID: 27585692
[TBL] [Abstract][Full Text] [Related]
45. The many faces and functions of β-catenin.
Valenta T; Hausmann G; Basler K
EMBO J; 2012 Jun; 31(12):2714-36. PubMed ID: 22617422
[TBL] [Abstract][Full Text] [Related]
46. Structural basis of coactivation of liver receptor homolog-1 by β-catenin.
Yumoto F; Nguyen P; Sablin EP; Baxter JD; Webb P; Fletterick RJ
Proc Natl Acad Sci U S A; 2012 Jan; 109(1):143-8. PubMed ID: 22187462
[TBL] [Abstract][Full Text] [Related]
47. Dominant β-catenin mutations cause intellectual disability with recognizable syndromic features.
Tucci V; Kleefstra T; Hardy A; Heise I; Maggi S; Willemsen MH; Hilton H; Esapa C; Simon M; Buenavista MT; McGuffin LJ; Vizor L; Dodero L; Tsaftaris S; Romero R; Nillesen WN; Vissers LE; Kempers MJ; Vulto-van Silfhout AT; Iqbal Z; Orlando M; Maccione A; Lassi G; Farisello P; Contestabile A; Tinarelli F; Nieus T; Raimondi A; Greco B; Cantatore D; Gasparini L; Berdondini L; Bifone A; Gozzi A; Wells S; Nolan PM
J Clin Invest; 2014 Apr; 124(4):1468-82. PubMed ID: 24614104
[TBL] [Abstract][Full Text] [Related]
48. Structural analyses of death domains and their interactions.
Park HH
Apoptosis; 2011 Mar; 16(3):209-20. PubMed ID: 21207148
[TBL] [Abstract][Full Text] [Related]
49. The molecular perspective: cadherin.
Goodsell DS
Stem Cells; 2002; 20(6):583-4. PubMed ID: 12456966
[No Abstract] [Full Text] [Related]
50. Structural insights into the inhibition of Wnt signaling by cancer antigen 5T4/Wnt-activated inhibitory factor 1.
Zhao Y; Malinauskas T; Harlos K; Jones EY
Structure; 2014 Apr; 22(4):612-20. PubMed ID: 24582434
[TBL] [Abstract][Full Text] [Related]
51. Exploring the structural significance of molecular switch mechanism alias motif phosphorylation in Wnt/β-catenin and their crucial role in triple-negative breast cancer.
Sriroopreddy R; Raghuraman P; Sreeshma J; Kamalesh D; Sudandiradoss C
Arch Biochem Biophys; 2021 Feb; 698():108722. PubMed ID: 33321112
[TBL] [Abstract][Full Text] [Related]
52. Structural and thermodynamic characterization of cadherin·β-catenin·α-catenin complex formation.
Pokutta S; Choi HJ; Ahlsen G; Hansen SD; Weis WI
J Biol Chem; 2014 May; 289(19):13589-601. PubMed ID: 24692547
[TBL] [Abstract][Full Text] [Related]
53. FMRP recruitment of β-catenin to the translation pre-initiation complex represses translation.
Ehyai S; Miyake T; Williams D; Vinayak J; Bayfield MA; McDermott JC
EMBO Rep; 2018 Dec; 19(12):. PubMed ID: 30361391
[TBL] [Abstract][Full Text] [Related]
54. Monitoring interactions and dynamics of endogenous beta-catenin with intracellular nanobodies in living cells.
Traenkle B; Emele F; Anton R; Poetz O; Haeussler RS; Maier J; Kaiser PD; Scholz AM; Nueske S; Buchfellner A; Romer T; Rothbauer U
Mol Cell Proteomics; 2015 Mar; 14(3):707-23. PubMed ID: 25595278
[TBL] [Abstract][Full Text] [Related]
55. Issues associated with assessing nuclear localization of N-terminally unphosphorylated beta-catenin with monoclonal antibody 8E7.
Maher MT; Flozak AS; Hartsell AM; Russell S; Beri R; Peled ON; Gottardi CJ
Biol Direct; 2009 Feb; 4():5. PubMed ID: 19187541
[TBL] [Abstract][Full Text] [Related]
56. Looking beyond the Wnt pathway for the deep nature of β-catenin.
Fagotto F
EMBO Rep; 2013 May; 14(5):422-33. PubMed ID: 23598517
[TBL] [Abstract][Full Text] [Related]
57. Parallel and Sequential Pathways of Molecular Recognition of a Tandem-Repeat Protein and Its Intrinsically Disordered Binding Partner.
Smith BM; Rowling PJE; Dobson CM; Itzhaki LS
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34206070
[TBL] [Abstract][Full Text] [Related]
58. Mechanical properties of β-catenin revealed by single-molecule experiments.
Valbuena A; Vera AM; Oroz J; Menéndez M; Carrión-Vázquez M
Biophys J; 2012 Oct; 103(8):1744-52. PubMed ID: 23083718
[TBL] [Abstract][Full Text] [Related]
59. Identification of paxillin domains interacting with β-catenin.
Dubrovskyi O; Tian X; Poroyko V; Yakubov B; Birukova AA; Birukov KG
FEBS Lett; 2012 Jul; 586(16):2294-9. PubMed ID: 22728435
[TBL] [Abstract][Full Text] [Related]
60. [Perspectives on structure elucidation of the cadherin-catenin complex].
Kurokawa H; Ikura M
Seikagaku; 2006 Jul; 78(7):595-600. PubMed ID: 16910552
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
